November 02, 2011
Breckenridge Pharmaceutical Inc. on Wednesday accused rival drugmakers UCB Inc. and Kremers Urban Pharmaceuticals Inc. of marketing prescription versions of Breckenridge's generic laxative product, despite a former agreement to stop distributing the drug.